FD&C Red 3


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001835 Body Weight PMID:11313110; PMID:2177442; PMID:2824305
MESH:D001986 Bronchial Spasm PMID:447949
MESH:D002869 Chromosome Aberrations PMID:16406784
MESH:D003643 Death PMID:6314928
MESH:D004487 Edema PMID:39843243
MESH:D006529 Hepatomegaly PMID:39843243
MESH:D006948 Hyperkinesis PMID:20465369
MESH:D006967 Hypersensitivity PMID:150265
MESH:D007674 Kidney Diseases PMID:32981412; PMID:39843243
MESH:D009374 Neoplasms, Experimental PMID:2836348
MESH:D009422 Nervous System Diseases PMID:6318389
MESH:D009436 Neural Tube Defects PMID:31715407
MESH:D009845 Oligospermia PMID:9299211
MESH:D012220 Rhinitis PMID:14763933
MESH:D013733 Testicular Diseases PMID:33565293
MESH:D013964 Thyroid Neoplasms PMID:2836348
MESH:D015430 Weight Gain PMID:39400474; PMID:39600142; PMID:39843243
MESH:D019954 Neurobehavioral Manifestations PMID:11313110
MESH:D020258 Neurotoxicity Syndromes PMID:265392
MESH:D053627 Asthenozoospermia PMID:9299211
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:39843243

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.